MEFOXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mefoxin, and what generic alternatives are available?
Mefoxin is a drug marketed by Mylan Institutional and Merck and is included in four NDAs.
The generic ingredient in MEFOXIN is cefoxitin sodium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for MEFOXIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Clinical Trials: | 1 |
Patent Applications: | 5,392 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEFOXIN at DailyMed |
Recent Clinical Trials for MEFOXIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bristol-Myers Squibb | N/A |
University of KwaZulu | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for MEFOXIN
US Patents and Regulatory Information for MEFOXIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Institutional | MEFOXIN | cefoxitin sodium | INJECTABLE;INJECTION | 062757-001 | Jan 8, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | cefoxitin sodium | INJECTABLE;INJECTION | 050581-004 | Sep 20, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Institutional | MEFOXIN | cefoxitin sodium | INJECTABLE;INJECTION | 050517-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Institutional | MEFOXIN IN PLASTIC CONTAINER | cefoxitin sodium | INJECTABLE;INJECTION | 063182-001 | Jan 25, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |